BEAM-302

· Beam Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BEAM-302, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD) [Phase 1, Phase 2]

See pricing